Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 23Unknown 16Terminated 10Not yet recruiting 2Recruiting 1No longer available 1Active not recruiting 1

Sponsor Class

OTHER 4916INDUSTRY 830OTHER_GOV 203NETWORK 39NIH 30FED 9UNKNOWN 2INDIV 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Myasthenia Gravis 2

Interventions

blinatumomab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × INDIV × Clear all
NCT07079020 2025-07-22

Efgartigimod for Consolidation Therapy in gMG

Da, Yuwei, M.D.

Not yet recruiting
130 enrolled

Myasthenia Gravis

NCT06836973 2025-03-25

Blinatumomab for Treatment of Refractory Myasthenia Gravis

Da, Yuwei, M.D.

Phase 2/3 Not yet recruiting
2 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡